Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Mar-24 8:36 PM View:  | Stoke Therapeutics, Inc. (STOK) | 19-Mar-24 | Option Sale | 4,116 | $6.10 | $25,101.80 | (17%) 24.86K to 20.75K | |
| 19-Mar-24 8:36 PM View: | Stoke Therapeutics, Inc. (STOK) | 15-Mar-24 | Option Exercise | 13,100 | -- | -- | 111% 11.76K to 24.86K | |
| 03-Jun-22 5:00 PM View: | Stoke Therapeutics, Inc. (STOK) | 02-Jun-22 | Option Exercise | 11,160 | $4.48 | $49,996.80 | 1854% 0.6K to 11.76K | |
| 24-Feb-21 5:15 PM View: | Stoke Therapeutics, Inc. (STOK) | 23-Feb-21 | Option Exercise | 5,000 | $4.48 | $22,400.00 | 831% 0.6K to 5.6K | |
| 24-Feb-21 5:15 PM View: | Stoke Therapeutics, Inc. (STOK) | 23-Feb-21 | Market Option Sale (Planned) | 5,000 | $58.60 | $292,992.00 | (89%) 5.6K to 0.6K | 55% |
| 24-Feb-21 5:15 PM View: | Stoke Therapeutics, Inc. (STOK) | 22-Feb-21 | Option Exercise | 25,000 | $4.48 | $112,000.00 | 4153% 0.6K to 25.6K | |
| 24-Feb-21 5:15 PM View: | Stoke Therapeutics, Inc. (STOK) | 22-Feb-21 | Market Option Sale (Planned) | 25,000 | $58.92 | $1,472,900.00 | (98%) 25.6K to 0.6K | 55% |
| 04-Nov-20 5:31 PM View: | Stoke Therapeutics, Inc. (STOK) | 04-Nov-20 | Option Exercise | 33,268 | $4.48 | $149,041.00 | 5526% 0.6K to 33.87K | |
| 04-Nov-20 5:31 PM View: | Stoke Therapeutics, Inc. (STOK) | 04-Nov-20 | Planned Option Sale | 33,268 | $40.80 | $1,357,210.00 | (98%) 33.87K to 0.6K | |
| 04-Nov-20 5:31 PM View: | Stoke Therapeutics, Inc. (STOK) | 03-Nov-20 | Option Exercise | 1,732 | $4.48 | $7,759.36 | 288% 0.6K to 2.33K | |
| 04-Nov-20 5:31 PM View: | Stoke Therapeutics, Inc. (STOK) | 03-Nov-20 | Planned Option Sale | 1,732 | $39.84 | $68,997.50 | (74%) 2.33K to 0.6K | |
| 04-Nov-20 5:31 PM View: | Stoke Therapeutics, Inc. (STOK) | 02-Nov-20 | Option Exercise | 35,000 | $4.48 | $156,800.00 | 5814% 0.6K to 35.6K | |
| 04-Nov-20 5:31 PM View: | Stoke Therapeutics, Inc. (STOK) | 02-Nov-20 | Planned Option Sale | 35,000 | $37.25 | $1,303,730.00 | (98%) 35.6K to 0.6K | |
| 08-Mar-18 4:38 PM View: | Aldeyra Therapeutics, Inc. (ALDX) | 29-Dec-17 | Grant | 3,153 | $3.99 | $12,596.20 | 58% 5.41K to 8.56K | |
| 08-Mar-18 4:38 PM View: | Aldeyra Therapeutics, Inc. (ALDX) | 30-Jun-17 | Grant | 2,077 | $3.95 | $8,209.34 | 62% 3.33K to 5.41K | |
| 21-Feb-17 4:30 PM View: | Aldeyra Therapeutics, Inc. (ALDX) | 17-Feb-17 | Private Purchase | 3,333 | $4.50 | $14,998.50 | 100% 0 to 3.33K | |
| 02-Jul-10 3:14 PM View: | Javelin Pharmaceuticals, Inc. (JAV) | 02-Jul-10 | Disposition | 12,500 | $2.20 | $27,500.00 | (100%) 12.5K to 0 | 0% |
| 02-Jul-10 3:14 PM View: | Javelin Pharmaceuticals, Inc. (JAV) | 30-Jun-10 | Disposition (change in control) | 10,115 | $2.20 | $22,253.00 | (45%) 22.61K to 12.5K | 0% |
| 05-May-10 7:01 PM View: | Javelin Pharmaceuticals, Inc. (JAV) | 03-May-10 | Market Sale | 2,385 | $2.18 | $5,199.54 | (10%) 25.0K to 22.61K | (< 1%) |
| 22-Dec-09 5:37 PM View: | Javelin Pharmaceuticals, Inc. (JAV) | 18-Dec-09 | Grant | 10,000 | -- | -- | 67% 15.0K to 25.0K | |
| 05-May-09 5:22 PM View: | Javelin Pharmaceuticals, Inc. (JAV) | 01-May-09 | Grant | 15,000 | -- | -- | 100% 0 to 15.0K |